Clinical trials show progress in migraine frequency, skin cancer prevention

-
5:11
No closer to finalizing state budget and reworking testing standards
-
0:55
People gather to keep the city public museum open
-
2:17
Girls On The Run 5K draws in thousands to empower young girls
-
1:34
18-year-old shot and killed; Milwaukee residents wake up to gunshots
-
1:41
Schlesinger’s Saturday Showcase (5/31)...Professional golf,...
-
2:34
Some smoke, some sun for the weekend followed by warmer weather...
-
0:24
Ike Wynter Turns Top Chef set into Art at Milwaukee Public Museum
-
1:54
’This is the place to be’: Festa Italiana kicks off in Milwaukee
-
2:50
’You never know what can happen’: Parents question why DEA...
-
1:00
Gov. Evers raises Pride flag over state Capitol in honor of Pride...
-
1:28
Milwaukee County Sheriff’s Office launches fitness camp to...
-
3:02
Undocumented Wisconsin immigrant accused of writing letter threatening...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.